MedTrace Logo

Cognitive-behavioral Therapy for Mental Disorder in COVID-19 Survivors

NCT05815693 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-06-29

No results posted yet for this study

Summary

The consequences of the Intensive Care Unit and the Covid-19 disease are still uncertain. However, many studies are bringing out often psychological and dramatic consequences for many COVID-survivor patients.

Among the ex-covid patients discharged from our Intensive Care Unit and with at least one covid-related psychological consequence, we want to evaluate the effectiveness for long-term consequences of COVID-19 of mindfulness-based stress reduction (MBSR) or usual care.

Conditions

  • Post Acute COVID-19 Syndrome

Interventions

BEHAVIORAL

mindfulness-based stress reduction (MBSR) and cognitive behavioral therapy (CBT)

Patients with long-term consequences of COVID-19 (Chronic pain, anxiety, depression or insomnia) enrolled and randomly assigned to receive MBSR (n = 63), or usual care (n = 62). MBSR (training in mindfulness meditation and yoga) were delivered in 12 months with 2-hour groups each 2 months. Usual care included anything care participants received such as drug therapy.

Sponsors & Collaborators

  • Azienda Socio Sanitaria Territoriale di Lecco

    lead OTHER

Principal Investigators

  • Vincenzo Damico · Azienda Socio Sanitaria Territoriale di Lecco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-13
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05815693 on ClinicalTrials.gov